Academic literature on the topic 'Alopecia areata'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Alopecia areata.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Alopecia areata"

1

Kramov, N. "Treatment of alopeciae areatae. Bengtson (T. Amer, M. A. v. 97. No. 19)." Kazan medical journal 32, no. 8-9 (October 4, 2021): 788. http://dx.doi.org/10.17816/kazmj81578.

Full text
Abstract:
Treatment of alopeciae areatae. Bengtson (T. Amer, MA v. 97. No. 19), using pituitaris extract in 16 patients with alopecia areata, obtained excellent results: first lanugo appeared, and then hair, eyebrows, eyelashes, beard of the same color appeared, while the general condition improved. The patients were young and old.
APA, Harvard, Vancouver, ISO, and other styles
2

Toena, Haken Tennizar, and Retno Danarti. "Diagnosis Alopesia Areata Pada Anak: Kasus Serial." Cermin Dunia Kedokteran 49, no. 4 (April 1, 2022): 214. http://dx.doi.org/10.55175/cdk.v49i4.1824.

Full text
Abstract:
<p>Alopesia areata (AA) merupakan penyakit autoimun yang ditandai dengan alopesia non-sikatrisial. Kondisi ini merupakan dermatosis yang umum ditemui pada anak. Gambaran klinisnya berupa alopesia non-sikatrisial fokal, perlu dibedakan dari kondisi dapatan serupa lainnya, terutama yang sering terjadi pada anak. Kami melaporkan 5 kasus AA pada anak berusia di bawah 18 tahun. Diagnosis berdasarkan pemeriksaan klinis dan penunjang. Pemahaman karakteristik AA perlu diketahui untuk diagnosis, terutama pada pasien anak.</p><p>Alopecia areata (AA) is a chronic autoimmune disease characterized by non-scarring alopecia. It is one of the most commonly found dermatosis in pediatric population. The clinical manifestations of focal non-scarring alopecia must be differentiated from other acquired focal non-scarring alopecia, especially those in children. This paper report 5 AA cases in children. Diagnosis was based on clinical and supporting examinations. Understanding the characteristics of AA, particularly in children, is important to make correct diagnosis.</p>
APA, Harvard, Vancouver, ISO, and other styles
3

Tzur Bitan, Dana, Daniella Berzin, Khalaf Kridin, Yaron Sela, and Arnon Cohen. "Alopecia Areata as a Proximal Risk Factor for the Development of Comorbid Depression: A Population-based Study." Acta Dermato-Venereologica 102 (March 14, 2022): adv00669. http://dx.doi.org/10.2340/actadv.v102.1622.

Full text
Abstract:
Alopecia areata and depression tend to co-occur; however, their temporal association has not been comprehensively investigated. The aim of this study was to examine the temporal association between alopecia areata and depression. The study included only cases with a comorbid presentation of alopecia areata and depression (n = 1,936), extracted from the databases of the Clalit Health Services, Israel. Survival analyses were used to assess the cumulative probability of receiving alopecia areata as comorbid diagnosis in the years following depression, and vice versa, compared with the opposite trajectory. The results indicate that patients with alopecia areata had greater odds of subsequent depression within 2 years from alopecia areata diagnosis, and showed a steeper increase in cumulative probability of depression as time progressed (log-rank =336.38, p < 0.001), compared with the opposite trajectory. All patients with alopecia areata had comorbid depression within 10 years of alopecia areata, compared with 70% of depression patients receiving diagnoses of comorbid alopecia areata within the same time-frame.
APA, Harvard, Vancouver, ISO, and other styles
4

Yong, Angeline Anning, and Robin Unger. "Resistance of Transplanted Hair Follicles to the Onslaught of Diffuse Alopecia Areata." American Journal of Cosmetic Surgery 34, no. 2 (March 23, 2017): 70–72. http://dx.doi.org/10.1177/0748806817699926.

Full text
Abstract:
A 55-year-old man who previously underwent a successful hair transplantation for androgenetic alopecia now presents with rapid onset hair loss over the anterior to mid-scalp areas during a 2-month period. The alopecic area noticeably extended diffusely from anterior hairline to scalp vertex while rows of previously transplanted hair follicles appeared intact. Further dermoscopic features and a scalp biopsy were consistent with alopecia areata incognita. This patient was subsequently successfully treated with intralesional steroid injections. This case report is the first demonstrating the relative resistance of transplanted hair follicles to the process of alopecia areata when compared with local indigenous hairs. Prior to this, a few reports have demonstrated the use of hair transplantation to treat stable areas of alopecia areata resistant to medical treatment with mixed results but at least some initial success. This could be related to the local irritation and inflammatory response resultant from needling during hair transplantation that causes a degree of scarring and fibrosis around each transplanted graft, hence lending a protective barrier to an autoimmune-based T-lymphocyte attack on hair bulbs and subsequent increased survival of transplanted hair follicles. This unexpected observation provides new avenues for investigation into alopecia areata pathophysiology and further supports hair transplantation as a viable option for patients with stable, localized alopecia areata that is recalcitrant to other modalities.
APA, Harvard, Vancouver, ISO, and other styles
5

Kirshen, Carly, and Nordau Kanigsberg. "Alopecia Areata following Adalimumab." Journal of Cutaneous Medicine and Surgery 13, no. 1 (January 2009): 48–50. http://dx.doi.org/10.2310/7750.2008.07095.

Full text
Abstract:
Background: Alopecia areata is a nonscarring hair loss characterized by well-circumscribed patchy areas, most often on the scalp. The inflammatory cytokine tumor necrosis factor alpha (TNF-α), has been connected with the development of alopecia areata in vivo; thus, the TNF-α inhibitors have been cited as possible treatments for this autoimmune condition. Objective: We report a case of alopecia areata that developed in a 52-year-old woman who was recently started on adalimumab for treatment of her psoriatic arthritis. Results: We discuss the previously published cases in the literature linking alopecia areata to TNF-α inhibitor administration. Our case is the first report of a new-onset alopecia areata following adalimumab. Conclusions: Even though TNF-α is implicated in causing alopecia areata, TNF-α inhibitors have paradoxically been associated with new cases of alopecia areata. It is possible that TNF-α may not be involved in the pathogenesis of alopecia areata, as in vitro studies have suggested.
APA, Harvard, Vancouver, ISO, and other styles
6

Sousa, Brunna Michelly da Silva, Thaís Jales Natal, Tamyres Borges Pereira, Mariana Vieira Martins Sampaio Drummond, and Roberpaulo Anacleto Neves. "Análise comparativa entre os tratamentos para alopecia: uma revisão sistemática." Research, Society and Development 10, no. 15 (November 21, 2021): e134101522770. http://dx.doi.org/10.33448/rsd-v10i15.22770.

Full text
Abstract:
Introdução: A alopecia é a ausência temporária ou congênita de pelos ou cabelos, podendo ser classificada em cicatricial e não cicatricial. Esse estudo focou na análise comparativa dos tratamentos da alopecia areata e androgenética, as quais são alopecias não cicatriciais. A alopecia androgenética é a forma mais comum de perda de cabelo na espécie humana e a alopecia areata possui acometimento de cerca de 2% no âmbito mundial. Objetivo: O estudo visou conhecer, correlacionar e comparar as diferentes formas de tratamento para a alopecia areata e androgenética nos estudos mais recentes. Método: Trata-se de uma revisão sistemática de artigos científicos publicados na base de dados PUBMED entre 01/01/2018 e 31/12/2018. Foram usados os descritores “alopecia areata and treatment” e “alopecia androgenetic and treatment”. Primeiro, os artigos foram analisados pelo título e resumo/abstract por dois revisores (BMSS e TJ), e em caso de desacordos, um terceiro revisor foi consultado (RAN). A seguir, houve uma leitura completa dos textos, e em caso de desacordos, um último revisor foi consultado (RAN). Resultados: A busca por “alopecia areata and treatment” resultou em 26 registros, dos quais 14 foram excluídos. Após a leitura dos artigos na íntegra, dentre os 12 artigos, apenas sete foram utilizados. A busca por “alopecia androgenetic and treatment” resultou em 84 registros, dos quais 61 artigos não atenderam aos critérios de inclusão. Após lidos os 24 artigos, apenas nove foram selecionados. Logo, após a fase de seleção, 16 artigos permaneceram elegíveis. Conclusão: Há uma vasta gama de tratamentos para a alopecia, mostrando que o tratamento deve ser individualizado para cada paciente. Deve-se lembrar sempre de associar a terapia farmacológica ao acompanhamento psicológico, uma vez que o cabelo é também é um instrumento de comunicação.
APA, Harvard, Vancouver, ISO, and other styles
7

Papadopoulos, Anthony J., Robert A. Schwartz, and Camilakrysicka Janniger. "Alopecia Areata." American Journal of Clinical Dermatology 1, no. 2 (March 2000): 101–5. http://dx.doi.org/10.2165/00128071-200001020-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lun E. Hon, Kam, and Alexander K.C. Leung. "Alopecia Areata." Recent Patents on Inflammation & Allergy Drug Discovery 5, no. 2 (May 1, 2011): 98–107. http://dx.doi.org/10.2174/187221311795399291.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Otlewska, Anna, Agnieszka Otlewska, and Grzegorz Szpotowicz. "Alopecia areata." Pediatria i Medycyna Rodzinna 15, no. 4 (December 31, 2019): 358–61. http://dx.doi.org/10.15557/pimr.2019.0060.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bujan, Maria. "Alopecia areata." Archivos Argentinos de Pediatria 111, no. 5 (October 1, 2013): 455–56. http://dx.doi.org/10.5546/aap.2013.455.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Alopecia areata"

1

Wang, Eddy Hsi Chun. "The pathogenesis of alopecia areata." Thesis, University of British Columbia, 2014. http://hdl.handle.net/2429/51360.

Full text
Abstract:
The development of a hair loss disease, alopecia areata (AA), is believed to be associated with the initiation of an autoimmune response triggered by the activation of cytotoxic T-cells (CTLs) by unidentified autoantigen epitopes. The long-term sequelae of AA also have not received investigation beyond clinical observations. I hypothesized that CTLs in AA can be activated by autoantigen epitopes derived from hair follicle (HF) cells and activated CTLs may affect the viability of HF keratinocytes. Furthermore, I hypothesized the development of AA can have adverse effects on heart health and induce apoptosis of cardiomyocytes mediated in part by stress hormones. To test these hypotheses, I stimulated AA human peripheral blood mononuclear cells (PBMCs) and mouse LNCs with HF autoantigen epitope peptides. I showed that trichohyalin (TCHH) peptides induced higher frequencies of AA PBMC activation and led to keratinocyte apoptosis, while cytokeratin 16 (KRT16) peptides activate more AA mouse LNCs; both indicating the importance of keratinocyte autoantigens in AA pathogenesis. We showed that AA mice displayed significantly heavier hearts and collagen deposition in hearts compared to controls. Exposure of heart tissues to stress hormone adrenocorticotrophic hormone (ACTH) resulted in differential expression of interleukin-18 (Il18) genes and increased secretion of cardiac disease marker cardic troponin-I (cTnI). AA patients showed highest levels of cTnI compared to androgenetic alopecia (AGA) and no-hair-loss (NHL) groups. Culturing of cardiomyocytes with plasma from AA subjects with higher levels of cTnI also resulted in higher levels of apoptosis compared to cultures with plasma expressing low levels of cTnI; suggesting presence of harmful factors in the plasma. Additionally, to prove AA is a cell-mediated disease, we established a new mouse model of AA via injecting naïve C3H/HeJ mice with cultured LNCs isolated from spontaneously affected AA mice. In conclusion, AA pathogenesis is associated with higher frequencies of PBMC or LNC activation upon keratinocyte antigen epitope challenge and AA development resulted in changes in gene expression and heart morphology in mice and heart tissue remodeling markers in humans.
Medicine, Faculty of
Medicine, Department of
Experimental Medicine, Division of
Graduate
APA, Harvard, Vancouver, ISO, and other styles
2

Wendel, Caroline. "Kortikosteroider som behandling mot Alopecia Areata." Thesis, University of Kalmar, School of Pure and Applied Natural Sciences, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:hik:diva-287.

Full text
Abstract:

Alopecia areata (AA) betyder fläckvis håravfall och uppstår vanligen på huvudet men även på kroppen. Det är en harmlös, reversibel, organ-specifik, autoimmun hudsjukdom som drabbar hårfolliklarna. Den autoimmuna reaktionen förmedlas av T-lymfocyter som angriper hårfolliklarna och hämmar hårväxt. Det årliga incidenstalet för både kvinnor och män är 20,2 per 100 000 personer och 1,7 % av befolkningen riskerar att drabbas någon gång under livet. Även om genetiskt anlag och miljöfaktorer, såsom emotionell stress, graviditet och tillfälliga infektioner kan utlösa sjukdomen så är den exakta orsaken fortfarande okänd. De behandlingar som finns mot AA påverkar inte den autoimmuna processen som orsakar alopecin utan syftet med dessa är att stimulera hårfolliklarna och dämpa sjukdomens aktivitet. Kortikosteroider används vid behandling mot AA, men kan ge svåra biverkningar vid långvarig behandling. De olika administrationsformer av kortikosteroider som används mot AA är främst lokala och systemiska, men även intralesionella.

Målet med denna litteraturstudie var att undersöka om kortikosteroider har någon effekt mot AA. Samtliga studier visade att kortikosteroider har effekt mot AA, men att risken för återfall är stor. Tre av de fem studierna visade att behandlingen gav bättre resultat hos de patienterna med mindre svår AA, kort duration och första episoden av sjukdomen. Dåliga prognostiska faktorer visade sig vara omfattande AA, lång duration, atopi, nagelinvolvering och flera episoder av sjukdomen.

En studie visade att patienter med plurifocal AA svarar bättre på behandlingen än patienter med ophiasic AA, AA totalis och AA universalis. I samtliga studier fick patienterna biverkningar av behandlingen med dessa var inte så allvarliga att patienterna fick avbryta behandlingen. Slutsatsen av detta arbete är att kortikosteroider har effekt mot AA, men att risken för återfall är stor.

2008:F3

APA, Harvard, Vancouver, ISO, and other styles
3

Olsen, E. A., M. K. Hordinsky, V. H. Price, J. L. Roberts, J. Shapiro, D. Canfield, M. Duvic, et al. "Alopecia areata investigational assessment guidelines ¿ part ii." American Academy of Dermatology, 2004. http://hdl.handle.net/10454/4042.

Full text
Abstract:
no
Alopecia areata is an immunologically mediated disease characterized by extreme variability not only in the time of initial onset of hair loss but in the duration, extent and pattern of hair loss during any given episode of active loss. These variables, as well as the unpredictable nature of spontaneous regrowth and lack of a uniform response to various therapies, has made clinical trials in alopecia areata difficult to plan and implement. In fact, there are currently no drugs FDA-approved specifically for the indication of alopecia areata. To help facilitate well-controlled clinical trials for alopecia areata, this National Alopecia Areata Foundation (NAAF) sponsored subgroup of investigators/clinicians experienced in clinical trials and/or in the clinical care of patients with alopecia areata has outlined some general principles and potential endpoints for clinical studies in alopecia areata. These guidelines build on the Alopecia Areata Investigational Assessment Guidelines published in 1991 which established baseline clinical staging and background information important to gather on any alopecia areata patient involved in clinical research.
APA, Harvard, Vancouver, ISO, and other styles
4

Funabashi, Marcia Yuri. "Alopecia areata no caso Flora: uma investigação psicopatológica." Pontifícia Universidade Católica de São Paulo, 2006. https://tede2.pucsp.br/handle/handle/15477.

Full text
Abstract:
Made available in DSpace on 2016-04-28T20:39:13Z (GMT). No. of bitstreams: 1 Dissertacao Marcia Yuri Funabashi.pdf: 436435 bytes, checksum: 05dd978753a97d140a232a0e634f0457 (MD5) Previous issue date: 2006-05-31
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
A investigação psicanalítica das manifestações somáticas levanta o enigma acerca da sua causalidade psíquica ao apostar na associação entre as vicissitudes destas doenças e questões da subjetividade. O tema desta dissertação retoma este impasse a partir da construção psicopatológica no caso Flora. Flora procura análise com a demanda de um saber sobre a alopecia areata universal, manifestação somática que rompeu com a sua lógica, deixando-a num completo desamparo. Ao tecer uma construção simbólica em torno da doença, Flora vai nos revelando a especificidade deste fenômeno. O conteúdo desta dissertação é uma mostra possível de um trabalho de elaboração em busca da palavra representativa do vivido na clínica. A construção metapsicológica resultante desta trajetória segue o pensamento da psicopatologia fundamental, sendo um produto de inúmeras reformulações promovidas pela escuta clínica e pelo constante diálogo com a teoria freudiana, de seus contemporâneos e com o discurso médico. Ao longo deste percurso de pesquisa, o estudo sobre a topologia lacaniana produziu um sentido na vivência clínica, ao sustentar que o corpo se estrutura a partir da articulação dos registros real, simbólico e imaginário, estabelecendo uma lógica precisa. Sendo assim, encontramos neste pensamento um eixo teórico para a compreensão da alopecia areata no caso Flora, através da investigação da estrutura presente nesta manifestação somática. A fim de alcançarmos uma maior compreensão acerca desta topologia de Lacan, realizamos uma releitura da metapsicologia freudiana, buscando resgatar idéias que deram subsídios para a proposta lacaniana. Com isso, juntamente com o retorno a Freud, avançamos com a posição de Lacan
APA, Harvard, Vancouver, ISO, and other styles
5

Hamed, Nagy. "Investigating the mechanisms underlying the pathogenesis of alopecia areata." Thesis, University of Sheffield, 2018. http://etheses.whiterose.ac.uk/20611/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Brand, Anna Maria [Verfasser]. "Vitamin-D-Status bei Alopecia areata : eine Metaanalyse / Anna Maria Brand." Saarbrücken : Saarländische Universitäts- und Landesbibliothek, 2020. http://d-nb.info/1225740967/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

West, Emma Kuliana. "Bald truths : living and coming to terms with alopecia areata hair loss." Thesis, University of Essex, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.537953.

Full text
Abstract:
This research set out to enhance our understanding of what it means to live with hair loss diagnosed as alopecia areata (AA), exploring how individuals adapted over time. This was achieved through depth interview with 33 persons (19 women; 14 men) living with various levels of hair loss severity and duration. There is a growing body of quantitative evidence indicating that the condition can be emotionally, psychologically and socially devastating. This investigation explored the issue qualitatively, directly from the perspectives of those affected, so as to gain a fuller perspective on negative outcomes for men and women. Results revealed how a great deal of uncertainty accompanied the early AA career and much effort was invested as individuals attempted to make sense of their experiences and exert control over the condition. As hair loss worsened and physical appearance became increasingly `different', questions of identity and self came to the fore, causing those affected to feel that the essence of their personhood was under threat. Over time some adapted more successfully than others, although those most zealous in their efforts to keep it hidden from others undoubtedly led the most restricted lives. Both men and women expressed negative feelings about their hair loss, particularly from the head and around the eyes. However, there were also clear gender differences in meanings according to hair loss in particular body areas. Moreover, women invested more in `normalising' their appearance. I have argued that simplistic assumptions regarding the heightened threat for women undermine the gravity for men and contribute towards the difficulty many men experience in seeking and gaining support. This research represents a preliminary step towards a fuller understanding of the experience of living with AA. It is anticipated that these findings will enable professionals to improve the planning and delivery of health care for A. A.
APA, Harvard, Vancouver, ISO, and other styles
8

Iorizzo, Matilde <1975&gt. "The role of scalp dermoscopy in the diagnosis of alopecia areata incognita." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2008. http://amsdottorato.unibo.it/1065/1/Tesi_Iorizzo_Matilde.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Iorizzo, Matilde <1975&gt. "The role of scalp dermoscopy in the diagnosis of alopecia areata incognita." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2008. http://amsdottorato.unibo.it/1065/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Styring, Nicola. "Examining the predictive utility of the theory of cognitive adaptation in relation to alopecia areata." Thesis, University of Sheffield, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.434455.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Alopecia areata"

1

Khan Mohammad Beigi, Pooya. Alopecia Areata. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-72134-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Alopecia areata. New York: The Rosen Pub. Group, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hordinsky, Maria K. Alopecia areata. Kalamazoo: Upjohn, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Alopecia areata. New York: Cavendish Square Publishing, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Atallah, Alvaro Nagib. Handbook of Alopecia areata Treatment: Best Evidence-Based Health Care - Cochrane Methodology. São Paulo, Brazil: Universidade Federal de São Paulo, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Thompson, Wendy J. A. Alopecia areata: Understanding and coping with hair loss. Baltimore: Johns Hopkins University Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Datsumō, hage wa akiramenaide watashi ni makasenasai. Tōkyō: Riohsha, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hunt, Nigel. Cómo vivir con la pérdida de cabello. México, D.F: Panorama Editorial, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hair loss: Principles of diagnosis and management of alopecia. London: Martin Dunitz., 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Women and Alopecia: Managing unexplained hair loss. London: Your Health Press in association with Trafford Publishing, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Alopecia areata"

1

Khan Mohammad Beigi, Pooya. "Alopecia Areata." In Alopecia Areata, 39–54. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-72134-7_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Khan Mohammad Beigi, Pooya. "Traction Alopecia." In Alopecia Areata, 67–68. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-72134-7_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jabbari, Ali, Lynn Petukhova, and Angela M. Christiano. "Alopecia Areata." In Clinical and Basic Immunodermatology, 527–35. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-29785-9_29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Happle, Rudolf. "Alopecia areata." In Fortschritte der praktischen Dermatologie und Venerologie, 173–78. Berlin, Heidelberg: Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71732-1_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Böhm, Markus. "Alopecia Areata." In European Handbook of Dermatological Treatments, 45–53. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-45139-7_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Möhrenschlager, M., and D. Abeck. "Alopecia areata." In Häufige Hautkrankheiten im Kindesalter, 9–14. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-44980-2_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lacarrubba, Francesco, Anna Elisa Verzì, Federica Dall’Oglio, and Giuseppe Micali. "Alopecia Areata." In Atlas of Pediatric Dermatoscopy, 147–54. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-71168-3_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rudnicka, Lidia, Malgorzata Olszewska, Adriana Rakowska, and Joanna Czuwara. "Alopecia Areata." In Atlas of Trichoscopy, 205–20. London: Springer London, 2012. http://dx.doi.org/10.1007/978-1-4471-4486-1_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Foitzik-Lau, Kerstin. "Alopecia Areata." In Harper's Textbook of Pediatric Dermatology, 149.1–149.8. Oxford, UK: Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444345384.ch149.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Freyschmidt-Paul, Pia, Kevin McElwee, and Rolf Hoffmann. "Alopecia Areata." In Autoimmune Diseases of the Skin, 463–96. Vienna: Springer Vienna, 2011. http://dx.doi.org/10.1007/978-3-211-99225-8_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Alopecia areata"

1

Aditya, S., Sanah Sidhu, and M. Kanchana. "Prediction of Alopecia Areata using Machine Learning Techniques." In 2022 IEEE International Conference on Data Science and Information System (ICDSIS). IEEE, 2022. http://dx.doi.org/10.1109/icdsis55133.2022.9915804.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

King, Brett, and Susanne Kammerer. "Alopecia areata: 1-year baricitinib treatment increases success." In 2022 American Academy of Dermatology Annual Meeting, edited by Peter van de Kerkhof. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/75326def.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

King, Brett, and Susanne Kammerer. "Alopecia areata: 1-year baricitinib treatment increases success." In 2022 American Academy of Dermatology Annual Meeting, edited by Peter van de Kerkhof. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/b8230aba.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kammerer, Susanne. "Alopecia areata pathogenesis: known genetic background, unknown environmental triggers." In 7th Congress of the SPIN, edited by Peter van de Kerkhof. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/1407d353.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kammerer, Susanne. "Alopecia areata: light at the end of the tunnel." In 7th Congress of the SPIN, edited by Peter van de Kerkhof. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/f395271f.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kammerer, Susanne. "Long-term improvement in alopecia areata with ritlecitinib therapy." In EADV Congress 2022, edited by Peter van de Kerkhof. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/245ff631.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

ARAÚJO, ANA LUÍSA MOREIRA BARREIRO DE, JOSEFA IZABELE LOPES BATISTA, MARIA IZADORA DE CALDAS FRANCELINO, NATHÁLIA CARLOS DE FREITAS LIMA QUEIROGA, and TIAGO BEZERRA DE SÁ DE SOUSA NOGUEIRA. "A INFLUÊNCIA DO ESTRESSE OXIDATIVO NO AGRAVAMENTO DA ALOPECIA AREATA." In III Congresso Brasileiro de Saúde On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/iii-conbrasau/11796.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kammerer, Susanne. "Deuruxolitinib achieves hair regrowth, even in patients with severe alopecia areata." In EADV Congress 2022, edited by Peter van de Kerkhof. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/6ec2f53f.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

"PTPN221858C>T gene polymorphisms in Alopecia Areata: A case–control association study in Iranian population." In International Conference on Medicine, Public Health and Biological Sciences. CASRP Publishing Company, Ltd. Uk, 2016. http://dx.doi.org/10.18869/mphbs.2016.67.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

LI, Huan, Ming BAI, Yan-yan MIAO, Xiao-yan FANG, and Ming-san MIAO. "Analysis of Animal Models of Alopecia Areata(AA) Based on Clinical Features of Traditional Chinese and Western Medicine." In 2nd International Conference on Biomedical and Biological Engineering 2017 (BBE 2017). Paris, France: Atlantis Press, 2017. http://dx.doi.org/10.2991/bbe-17.2017.19.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Alopecia areata"

1

Gupta, Aditya, Maanasa Venkataraman, and Mary Bamimore. Relative efficacy of biologic agents for alopecia areata: protocol for a systematic review with quantitative syntheses of the evidence base. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, February 2022. http://dx.doi.org/10.37766/inplasy2022.2.0082.

Full text
Abstract:
Review question / Objective: We plan to conduct a network meta-analysis study on the relative effectiveness of biologic agents for alopecia areata. Condition being studied: Alopecia Areata. Eligibility criteria: Randomized and observational studies that investigated the impact of monotherapy with biologic agents for alopecia areata. Only evidence in English will be included; there will be no date restrictions.
APA, Harvard, Vancouver, ISO, and other styles
2

Ballestas, Natalia, and Gabriela Gomez. Relationship between alopecia areata and intestinal dysbiosis: a scoping review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chu, Xin qiao, Yaning Biao, Yufeng Guo, Chenxu Liu, Hanlin Zhao, and Yixin Zhang. The efficacy and safety of fire needle therapy for alopecia areata: a protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, February 2022. http://dx.doi.org/10.37766/inplasy2022.2.0053.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tang, Genhua, Jun Xiong, and Jun Chen. Plum-blossom needle plus Chinese herbal medicine for alopecia areata:A systematic review and meta-analysis protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2020. http://dx.doi.org/10.37766/inplasy2020.8.0038.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography